Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-06 02:14:00 - browse：594

Silhouette of a person with short hair taking a sip of red wine in a winery — coverage from STAT — MARCO BERTORELLO/AFP via Getty Images

In 1995, when Marion Nestle was on the committee drafting the Dietary Guidelines for Americans, things were run differently. She and other experts handled it all: deciding on nutrition-related research questions, collecting the evidence, issuing a scientific report, and then writing guidance for how Americans should eat.

When it came time for that last part — the writing — Nestle and two co-authors got together at a bar, ordered glasses of wine, and got to work. “I’m not kidding,” she said. At the time, the research suggested small amounts of alcohol reduced the risk of heart disease. The guidelines reflected that. “Alcoholic beverages have been used to enhance the enjoyment of meals by many societies throughout human history,” read a part of the 1995 document (a note Nestle says was added last-minute by a federal official who believed in wine’s benefits).

The issue of alcohol — and how much of it Americans should consume — is up for debate again as the dietary guidelines undergo updates and revisions, due in 2025. Already, there’s simmering debate over a growing body of research, plus clashing of interests and the same specter of controversy that’s followed the report since Nestle’s time.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Big Tobacco's 'harm reduction': Is it for real, or a sham?

WSS

STAT Report: Patient voices and perspectives

Cytokinetics CEO stresses company can launch heart drug on its own

Readers respond to H5N1 and livestock movements, and more

What it's like to live with paralysis for one psychologist

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Case highlights the risks of experimental stem cell therapy

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

BioMarin wins approval for gene therapy to treat hemophilia A

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Medicare proposal to cover medical devices draws a mixed reaction

Why patients can’t get everything they want on drug pricing

The high cost of giving birth even with insurance

How doctors’ personal politics affect patients

After affirmative action ruling, medical educators look to 'holistic review'

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

entertainment

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

'Investigate these claims': UFO transparency at center of House hearing

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Criminal prosecution for violating HIPAA: an emerging threat

Device maker Teleflex to acquire urology company for $600M

What to watch for from Zogenix and Amicus clinical trials

leisure time

leisure time

leisure time

leisure time